Search

Search Constraints

You searched for: Author/Creator Ito, Toshifumi

Search Results

1. Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment. Issue 5 (9th March 2021)

2. Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. Issue 1 (January 2015)

4. Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine. Issue 4 (20th September 2012)

5. Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy. Issue 3 (28th December 2021)

6. Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus‐related liver cirrhosis. Issue 10 (16th July 2019)

7. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy. Issue 10 (29th March 2016)

8. Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors' reply. Issue 2 (30th December 2021)

9. Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study. Issue 5 (7th August 2017)

10. Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct‐acting anti‐virals. Issue 10 (7th October 2021)